bevacizumab,cetuximab
roche,eli lilly
['fire-4']
dr. stintzing with fire-4 results. noted that 13% of patients declared ras wt on tissue had a liquid bx-detected ras mutation. #asco23
Medical oncologist: GI cancers & cancer of unknown primary + high quality & value-based cancer care delivery. @UTexasValue MSHCT student. Tweets mine.